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Summary
Introduction:  Obstructive  diseases  of  the  upper  airways  are  common  in  children  and  sometimes
difﬁcult  to  manage.  Non-invasive  positive-pressure  ventilation  (NPPV)  consists  of  delivering  con-
tinuous positive  pressure  during  all  or  part  of  the  respiratory  cycle  via  a  non-invasive  interface
(face mask  or  nasal  mask,  or  nasal  prongs).  NPPV  is  the  treatment  of  choice  for  severe  obstruc-
tive sleep  apnoea  in  children  and  should  be  considered  prior  to  tracheotomy  and  is  also  indicated
in the  case  of  persistent  sleep-disordered  breathing  following  surgical  treatment,  a  frequent
situation  in  children  with  a  malformation  of  the  head  and  neck  or  upper  airways.
Discussion:  A  simple  ventilator,  able  to  deliver  continuous  positive  airway  pressure,  is  sufﬁcient
is most  cases  in  otolaryngology.  The  interface  represents  the  major  technical  limitation  of  NPPV,
especially  in  infants  for  whom  no  appropriate  commercial  interface  is  available.  A  sleep  study
before and  after  initiation  of  NPPV,  followed  by  regular  follow-up  examinations,  is  essential  to
conﬁrm correction  of  gas  exchanges  and  sleep  quality  in  response  to  NPPV.
Conclusion:  Finally,  NPPV  must  be  performed  in  a  specialized  paediatric  centre  with  speciﬁc
expertise  in  this  ﬁeld.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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tIntroductionUpper  airway  obstruction  is  very  common  in  children.
The  main  aetiology  is  hypertrophied  tonsils  and  ade-
noids,  which  are  simple  to  diagnose  and  treat  in  the
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doi:10.1016/j.anorl.2012.06.001ast  majority  of  cases,  as,  in  the  absence  of  concomi-
ant  disease  or  comorbidity  such  as  obesity,  tonsillectomy
nd  adenoidectomy  ensure  complete  correction  of  airway
bstruction.  In  the  case  of  residual  obstructive  syndrome
fter  tonsillectomy  and  adenoidectomy,  the  combination  of
 leukotriene  receptor  antagonist  and  topical  nasal  cor-
icosteroids  has  been  demonstrated  to  be  effective  [1].
owever,  upper  airway  obstruction  can  also  be  due  to
arer  diseases  such  as  malformations  of  the  head  and  neck
Pierre  Robin  sequence,  craniostenosis,  pycnodysostosis,
ranceschetti  syndrome,  achondroplasia,  storage  diseases)
served.
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Figure  3  Patient  with  craniostenosis  and  severe  obstructive
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cigure  1  Infant  with  Pierre  Robin  sequence  ventilated  via
asal mask.
nd  upper  airways  (congenital  or  acquired  laryngotracheal
tenosis,  laryngomalacia,  tracheomalacia,  lymphangioma)
Figs.  1  and  2).  In  these  diseases,  surgical  management  is
ften  partially  effective  to  enlarge  the  airway,  but  in  some
ases  surgery  may  be  impossible  or  even  contraindicated.
on-invasive  positive-pressure  ventilation  (NPPV)  is  partic-
larly  useful  in  these  situations  by  increasing  the  calibre  of
he  upper  airways  throughout  the  respiratory  cycle  by  main-
aining  continuous  positive  airway  pressure  (CPAP).  NPPV  is
urrently  recommended  before  tracheotomy,  which,  even
nly  a  few  years  ago,  remained  the  only  solution  after  failure
f  surgery.  This  non-invasive  ventilatory  assistance  tech-
ique  is  associated  with  much  lower  morbidity  and  mortality
nd  a  much  better  quality  of  life  than  tracheotomy  [2—4].
NPPV  is  a  ventilatory  assistance  technique  that  preserves
he  patient’s  upper  airways  in  contrast  with  endotracheal
ntubation,  laryngeal  mask,  and  tracheotomy.  It  consists  of
elivering  positive  pressure  during  all  or  part  of  the  respi-
atory  cycle  via  a  nasal  mask,  face  mask  or  nasal  prongs,
epending  on  the  patient’s  age,  tolerance,  or  facial  mor-
hology  (Fig.  3).  NPPV  has  been  extensively  developed
n  infants  over  recent  years  and  now  occupies  an  impor-
ant  place  in  the  management  of  upper  airway  obstructive
Figure  2  Obese  patient  ventilated  via  nasal  prongs.
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rleep apnoea  syndrome  despite  several  neurosurgical  and  head
nd neck  operations:  NPPV  via  face  mask.
isease,  as  CPAP  maintains  or  increases  the  calibre  of  the
pper  airways  throughout  the  respiratory  cycle.  The  major
dvantage  of  NPPV  is  maintenance  of  a  minimum  positive
ressure  throughout  the  respiratory  cycle,  during  both  inspi-
ation  and  expiration.
The  efﬁcacy  of  NPPV  is  due  to  the  fact  that  resistance  to
ow  of  a  ﬂuid  in  a tube,  like  air  in  the  upper  airways,  is  pro-
ortional  to  the  inverse  of  the  radius  to  the  power  of  four  [5].
 moderate  increase  of  airway  diameter,  maintained  patent
y  CPAP,  therefore  results  in  a  marked  reduction  of  resis-
ance.  As  in  adults,  NPPV  is  preferably  used  in  infants  during
leep,  associated  with  more  severe  airway  obstruction,  as
leep  is  associated  with  alteration  of  respiratory  mechanics
esulting  in  abnormalities  of  the  ventilation-perfusion  ratio,
ncreased  airway  resistance  and  decreased  residual  func-
ional  capacity.  Although  diaphragmatic  muscle  activity  is
reserved,  the  activity  of  intercostal  muscles  and  upper  air-
ay  muscles  is  signiﬁcantly  decreased  during  sleep.  Finally,
entilatory  control  and  the  activity  of  chemoreceptors  are
ess  effective  during  sleep  than  during  waking.  All  of  these
hanges  explain  the  physiological  reduction  of  alveolar  ven-
ilation  during  sleep.  This  hypoventilation  is  most  marked
uring  REM  sleep,  which  explains  why  infants  with  upper  air-
ay  obstruction  are  particularly  vulnerable  during  this  phase
f  sleep.
Due  to  its  non-invasive  nature,  its  relative  ease  of  use,
nd  the  fact  that  it  can  be  used  on  demand,  NPPV  is  the
referred  technique  for  home  ventilatory  assistance.  Edu-
ation  of  the  parents  and  the  child  takes  several  days  in  a
pecialized  centre,  even  for  young  infants.  NPPV  therefore
ow  constitutes  the  ﬁrst-line  treatment  for  severe  airway
bstruction  in  children  and  a  mandatory  alternative  to  tra-
heotomy  (Fig.  4).
iscussion
hy  treat  upper  airway  obstruction  in  children?any  studies  have  demonstrated  the  harmful  consequences
f  obstructive  sleep  apnoea  syndrome  in  children.  The  cor-
elation  between  apnoeas  and  sleep  fragmentation  related
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The efﬁcacy  of  NPPV  has  been  demonstrated  in  newborns
and  young  infants  with  marked  upper  airway  obstruction  in
the  context  of  Pierre  Robin  sequence  [11].  After  initiating
NPPV  in  the  intensive  care  unit,  these  infants  who  initially
had  less  than  30  min  of  ventilatory  autonomy,  were  able  to
return  home  with  NPPV  at  night  and  while  sleeping  during
the  day,  without  the  need  for  tracheotomy  (Fig.  1).
NPPV  can  also  be  indicated  to  facilitate  extubation,
which  would  otherwise  be  impossible  due  to  persistent
obstruction  during  sleep  [12]  (Fig.  6).
However,  it  is  difﬁcult  to  maintain  NPPV  24  h  a  day  in
the  long  term  and  a minimum  degree  of  cooperation  is
also  essential.  Nevertheless,  except  in  the  case  of  severe
psychomotor  retardation,  the  child’s  refusal  of  NPPV  is
an  exceptional  cause  of  failure.  Other  techniques  such
as  hypnosis  or  sophrology  can  be  particularly  useful  in
these  children  who  experience  expectant  anxiety  due  to
their  history  of  painful  or  traumatic  surgery.  In  every  case,
NPPV  constitutes  an  alternative  to  tracheotomy  and  must
always  be  discussed  and  attempted  before  considering  tra-
cheotomy.
Whenever  possible,  initiation  of  NPPV  must  be  planned
ahead  and  explained  to  the  child  and  the  family.  Initiation
of  NPPV  in  a  specialized  centre  is  particularly  impor-
Figure  5  Patient  with  Willi-Prader  syndrome:  NPPV  via  nasal
mask.Figure  4  Place  of  NPPV  in  upper  airway  obstructive  diseases
in children.
to  arousals  (real  or  cortical)  has  been  clearly  established.
Sleep  fragmentation  has  many  consequences,  sometimes
permanent,  on  the  child’s  neurocognitive  development
(memory  and  attention  disorders),  behaviour  (hyperactivity,
irritability,  agitation,  or  even  depression),  and  cardiovas-
cular  (hypertension)  and  metabolic  parameters  (systemic
inﬂammation  and  glucose  intolerance)  [6—10].  A  number  of
these  disorders  observed  in  adults  could  be  due  to  undi-
agnosed  and  untreated  obstructive  sleep  apnoea  during
childhood.
Indications  for  NPPV
No  validated  criteria  have  been  deﬁned  for  initiation  of
NPPV  in  children  with  upper  airway  obstructive  disease.  The
indication  for  NPPV  is  generally  based  on  the  presence  of
obstructive  sleep  apnoea  on  polysomnography  (PSG)  associ-
ated  with  suggestive  clinical  signs  such  as  apnoeas  observed
by  the  family,  persistent  snoring,  poor  quality  sleep  with
frequent  arousals,  agitated  sleep,  tiredness  on  awakening
and  during  the  day,  enuresis,  and  especially  irritability  and
concentration  and  memory  difﬁculties  (Fig.  5).  Nocturnal
blood  gas  abnormalities  with  hypoxaemia  and  nocturnal
hypercapnia  are  a  sign  of  severity  and  justify  initiation  of
NPPV.  A  trial  of  NPPV  can  also  be  considered  when  PSG  shows
only  moderate  abnormalities,  with  poor  sleep  efﬁcacy  and
fragmented  sleep,  but  with  the  presence  of  very  suggestive
clinical  signs  such  as  those  indicated  above.  The  decision
to  stop  or  continue  NPPV  is  then  based  on  the  results  of
another  PSG  and  clinical  assessment  performed  after  one
month  of  NPPV,  depending  on  the  beneﬁt  observed.  Sleep
quality  questionnaires  validated  in  children  are  very  useful
in  these  situations.
NPPV  requires  a  certain  degree  of  autonomous  ventilation
and  this  treatment  cannot  be  indicated  in  the  most  severe
patients  who  are  unable  to  breathe  unassisted  for  at  least  15
to  30  min.  However,  NPPV  has  a  residual  effect,  with  persis-
tence  of  the  beneﬁcial  effects  during  spontaneous  breathing
between  periods  of  NPPV  after  several  days  of  regular  use.
Figure  6  Patient  tracheotomised  at  the  age  of  1  month  due
to congenital  laryngeal  palsy  and  extubated  as  a  result  of  NPPV
via nasal  mask.
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ant  in  order  to  choose  the  most  appropriate  ventilator
nterface,  but  also  for  therapeutic  education  of  the  child
nd  the  family.  In  the  very  great  majority  of  cases,  no
ajor  problems  are  encountered  during  this  initiation  and
daptation  phase,  especially  when  NPPV  is  presented  as  an
lternative  to  tracheotomy.
odalities  of  NPPV
he  objective  of  NPPV  in  the  context  of  upper  airway
bstruction  is  to  maintain  sufﬁcient  opening  of  the  upper
irways  throughout  the  respiratory  cycle  during  sleep.  This
equires  selection  of  the  most  appropriate  ventilator  and
nterface.  The  ventilators  used  for  NPPV  are  CPAP  ventilators
ith  a  single-limb  circuit  and  clearance  of  carbon  dioxide
uring  expiration  via  a  calibrated  leak  system,  either  inte-
rated  into  the  interface  or  into  the  ventilator  circuit.  Many
mall,  lightweight,  and  inexpensive  ventilators  are  available
or  home  NPPV.  These  ventilators  are  not  battery-equipped
nd  have  limited  alarms,  but  as  this  type  of  ventilation
s  not  generally  ‘‘survival  ventilation’’,  these  options  are
ot  essential.  Bilevel  positive  airway  pressure  (BiPAP)  con-
ists  of  delivering  a  higher  pressure  during  inspiration.  The
dvantage  of  BiPAP  ventilation  compared  to  CPAP  in  terms
f  efﬁcacy  or  comfort  in  children  with  upper  airway  obstruc-
ion  has  not  been  demonstrated  [13].  Delivery  of  this  higher
ressure  during  inspiration  also  implies  that  the  ventilator  is
ble  to  detect  the  patient’s  inspiratory  trigger,  which  can  be
ery  difﬁcult  in  young  infants  due  to  the  very  low  ﬂows  and
olumes  involved,  that  cannot  be  detected  by  the  machine
14,15].  The  air  delivered  by  the  ventilator  is  humidiﬁed  and
eheated  by  the  nasal  fossae,  but  in  the  youngest  infants,
ddition  of  a  warm  humidiﬁer  can  improve  tolerability  and
omfort  of  NPPV,  especially  during  prolonged  use  during  the
ight  and  daytime  sleeping.
The  major  technical  limitation  of  NPPV  in  young  infants
oncerns  the  choice  of  interface  [16].  Although  many  nasal
nd  face  masks  are  available  for  older  children,  very  few
ommercial  masks  are  available  for  infants  and  young  chil-
ren  (Fig.  1).  No  satisfactory  commercial  mask  is  currently
dapted  to  infants  weighing  less  than  10  kg.  Custom-made
asks  that  can  only  be  made  in  specialized  centres  are
herefore  necessary  for  these  patients  [16,17].  Nasal  prongs
re  useful  interfaces  for  children  unable  to  support  a  face
ask  or  nasal  mask  or  with  facial  deformities  (Fig.  3).  Active
esearch  is  currently  underway  to  develop  adapted  and  easy-
o-use  interfaces  for  routine  NPPV  in  young  children  [16,18].
In  practice,  NPPV  in  children  must  be  performed  in  a  spe-
ialized  multidisciplinary  centre  with  speciﬁc  expertise.  It
s  initiated  during  the  day,  preferably  while  napping,  and
hen  at  night.  In  young  infants,  NPPV  is  usually  initiated  in
he  arms  of  one  of  the  parents.  A  nasal  mask  is  preferably
sed,  as  it  is  smaller  than  the  face  mask,  allowing  use  of  a
eat  in  infants,  which,  apart  from  its  soothing  properties,
lso  promotes  mouth  closure  and  avoids  leakages.  The  NPPV
djustment  period,  comprising  selection  of  the  most  suit-
ble  equipment,  correct  settings,  and  familiarization  of  the
hild  and  the  parents  with  the  equipment,  generally  takes
 days  to  2  weeks  with  a  mean  of  3  to  5  days  depending  on
he  child’s  age  and  acceptance.  A  minimum  of  6  h  of  con-
inuous  use  is  required  to  allow  the  child’s  return  home.
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leep  recordings  are  performed  during  the  initial  adjustment
hase  and  arterial  blood  gases  and  sleep  quality  must  be  nor-
al  prior  to  discharge.  Home  surveillance  is  performed  by
 homecare  technician  and/or  nurse,  who  must  have  pae-
iatric  training.  The  homecare  provider  must  be  contacted
hile  the  child  is  still  in  hospital  and  must  be  informed  about
he  date  of  discharge  so  that  the  ﬁrst  home  visit  can  be  held
n  the  day  of  discharge.  In  every  case,  parents  are  given
ritten  documents  providing  comprehensive  information  on
PPV  and  the  names  of  people  to  be  contacted  in  the  event
f  problem  24  h  a  day,  7  days  a  week.  Close  and  coordinated
ollaboration  between  the  sleep  centre  and  the  homecare
rovider  is  essential  for  follow-up  of  home  NPPV  in  children.
imitations,  complications
omplications  of  NPPV  in  children  are  rare  and  minor.  The
ain  problems  encountered  are  technical:  poorly  adapted
r  incorrectly  assembled  circuit,  ventilator  dysfunction,
efective  interface.  These  incidents  are  rare  with  CPAP
entilators.  Complications  of  NPPV  are  essentially  related
o  the  interface  and  consist  of  skin  lesions  and  facial
eformities  [17]. Skin  complications  can  be  prevented  or
reated  by  regularly  changing  the  interface  and/or  the  use
f  a  custom-made  mask  with  regular  review  of  acceptabil-
ty.  Custom-made  masks  induce  fewer  skin  complications
han  commercial  interfaces  [17].  Facial  deformities  such
s  ﬂattening  or  retrognathia  are  more  difﬁcult  to  pre-
ent  or  treat,  but  NPPV  often  constitutes  only  temporary
reatment  for  upper  airway  obstruction,  and  patients  can
e  usually  weaned  after  several  months  or  several  years.
acial  deformities  can  resolve  after  stopping  NPPV.  Pae-
iatric  maxillofacial  follow-up  is  therefore  systematically
ecommended  before  and  during  NPPV.  When  NPPV  needs
o  be  continued,  various  alternative  interfaces  can  be  pro-
osed,  including  nasal  prongs,  which  have  the  advantage  of
ot  requiring  any  forehead  support  [16]. New  nasal  prongs
or  very  young  infants  should  be  available  in  the  near
uture,  which  should  considerably  reduce  the  rate  of  skin
omplications  and  facial  deformities.
ollow-up
urveillance  of  NPPV  must  be  conducted  in  a centre  special-
zed  in  NPPV  in  children,  ideally  attached  to  a  paediatric
axillofacial  unit  in  order  to  prevent  and  detect  facial
omplications  related  to  the  interface  [17].  This  surveil-
ance  must  be  clinical,  respiratory,  ENT  and  maxillofacial,
echnical,  or  even  nutritional.  Overnight  hospitalisations  for
leep  recording  on  NPPV  are  performed  regularly  at  a  fre-
uency  determined  by  the  child’s  clinical  status  and  age.  The
hild  is  generally  reviewed  about  one  month  after  discharge,
hen  every  2  to  6  months  depending  on  the  child’s  age  and
linical  status.  The  interface,  ventilator  and  circuit,  venti-
ator  settings  and  at  least  nocturnal  arterial  blood  gases  and
leep  quality  with  NPPV  and  the  facial  and  skin  tolerance
f  the  mask  are  veriﬁed  during  overnight  hospitalisations.
ny  signs  of  skin  irritation  require  a change  or  adjustment
f  the  interface.  The  impact  of  the  interface  on  facial
rowth  is  determined  by  clinical  examination  [17].  Finally,
 complete  annual  assessment  is  recommended,  comprising
laryn
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[Non-invasive  positive-pressure  ventilation  in  children  in  oto
polysomnography  on  NPPV,  waking  arterial  blood  gases,  and
a  facial  assessment.
Regular  assessments  evaluate  the  course  of  the  obstruc-
tive  syndrome  in  order  to  possibly  propose  discontinuation
of  NPPV.  NPPV  must  be  withdrawn  progressively,  ﬁrst  dur-
ing  the  young  child’s  afternoon  nap  and  then  every  second
night  or  for  half  of  the  night,  under  clinical  and  polysomno-
graphic  surveillance.  NPPV  can  be  stopped  when  clinical
examination  and  a  sleep  study  on  spontaneous  breathing  are
normal,  but  surveillance  must  be  continued,  as,  due  to  the
residual  effect  of  NPPV,  the  obstructive  syndrome  can  recur
after  several  weeks  or  months,  constituting  an  indication  for
resumption  of  NPPV  [12].
Conclusion
NPPV  is  the  treatment  of  choice  for  severe  upper  airway
obstruction  in  children  after  failure  or  impossibility  of  surgi-
cal  treatment.  It  is  indicated  in  a  minority  of  children  with
upper  airway  obstructive  disease,  but  it  can  be  highly  ben-
eﬁcial  in  these  children  by  reducing  the  frequency  and/or
duration  of  tracheotomy.  Although  the  adverse  effects  of
NPPV  are  minor  and  despite  its  relative  simplicity,  this  treat-
ment  must  be  conducted  and  monitored  by  a  specialized
paediatric  centre.
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